Immediately prior to the Dispositions, ThreeD and the Joint Actor owned and controlled an aggregate of 15,996,257 common shares, 1,105,000 common share purchase warrants of the Company, and 50,000 stock options, representing approximately 13.6% of all issued and outstanding common shares of AVCN (or approximately 14.4% on a partially diluted basis, assuming exercise of the warrants and options held). Of this total, ThreeD held an aggregate of 9,902,300 common shares and 962,500 common share purchase warrants of the Company, representing approximately 8.4% of the issued and outstanding common shares of AVCN (or approximately 9.1% on a partially diluted basis, assuming exercise of the warrants held). The Joint Actor held an aggregate of 6,093,957 common shares, 142,500 common share purchase warrants, and 50,000 stock options of the Company, representing approximately 5.2% of the issued and outstanding shares of AVCN (or approximately 5.3% on a partially diluted basis, assuming exercise of the warrants and options held).